News

Genfit extends patent protection on GFT505 in major worldwide countries
Genfit identifies compounds which modulate clock genes for the treatment of cardiometabolic disease and CNS disorders
EuroBiO 2009
GENFIT PROGRESSES IN INNOVATIVE THERAPEUTIC APPROACHES IN ALZHEIMER’S DISEASE
GENFIT and BICOLL announce the identification of active compounds for inflammatory diseases
DIMETEX, Interreg IV programme
Eurasanté at BIO 2008, San Diego
All you need to know about the biotech industry is on EuroBiO 2007
The Nutrition Healthcare Longevity Cluster at BioJapan
A new R&D laboratory for Minakem
EuroBiOpartnering 2007 adopts a clear "tech transfer" focus